According to Dipan Mehta the correction seen in pharma stocks on back of the geo-political issues in Ukraine is an opportunity to buy into because going forward too there is growth coming in for pharma cos from US and developed East-European markets
first published: Mar 4, 2014 12:49 pm
A collection of the most-viewed Moneycontrol videos.

How SIP Top-Ups Can Boost Your Wealth | Smart Investing Made Simple

Nifty Reclaims 26,000; Nifty Bank Hits New Life High| Groww Joins RS 1 Lk Cr Club| Closing Bell Live

Nifty Headed For All-Time Highs After Friday’s Late Recovery?| Opening Bell Live

This Tenant Moved from a 100sqft Slum to a Premium Residence | The Tenant
You are already a Moneycontrol Pro user.

